New drug may cut transfusions after stem cell transplant
NCT ID NCT07450313
First seen Mar 07, 2026 · Last updated May 23, 2026 · Updated 6 times
Summary
This study tests if the drug luspatercept can improve anemia in 20 adults with blood cancers who have had a stem cell transplant. The main goal is to see if it reduces the need for red blood cell transfusions. Participants will receive the drug and be monitored for side effects and blood counts.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HSCT are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.